Gad Thomas

Y-mAbs Therapeutics, Inc. · CHIEF BUSINESS OFFICER

Gad Thomas is listed in filings as CHIEF BUSINESS OFFICER at Y-mAbs Therapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 18, 2025, including sale activity. Recent filings connect the profile to Y-mAbs Therapeutics, Inc. (YMAB). The current snapshot covers public activity from Jun 11, 2024 to Sep 18, 2025. Reported amounts are shown as $420.0K to $389.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Latest Trades

CompanyValueActionPriceCurrent Price
Y-mAbs Therapeutics, Inc.YMAB$57k10.8k sharesSellMar 7, 2025$5.23$8.61